ViaCyte’s attempts to develop a stem cell therapy for diabetes have been stymied by the immune system, which recognizes the implanted cells as foreign. Meanwhile, CRISPR Therapeutics has found success in gene-editing cells so that the cells avoid such immune responses.... Read more »
Most children aren’t diagnosed with autism until they’re at least 4 years old, and that’s something many experts hope can change. As with many conditions, treating autism earlier in life is believed to boost a child’s cognitive and social skills... Read more »
In August, Wayne State University held a ribbon-cutting ceremony for its new Mike Ilitch School of Business, a $40 million, state-of-the-art facility in Detroit’s Midtown neighborhood.
The business school announced another piece of good news this summer when alumnus Russ... Read more »
The FDA has cleared Mersana Therapeutics to resume enrolling patients in a study of an experimental cancer drug now that the Cambridge, MA, company is taking new precautions to protect patients from potential harm.
The company says the FDA lifted a... Read more »
Christopher Savoie says he was skeptical when former Harvard researcher Alán Aspuru-Guzik pitched Savoie last year on joining the quantum computing software venture he was planning to form.
Quantum computing technology is at least a decade away from commercial feasibility, responded... Read more »
Quantum computing is one of the most intriguing—and complex—areas of technology right now.
For years, it seemed like the field wouldn’t deliver practical applications any time soon. But that thinking has changed, and efforts at big companies, startups, and university research... Read more »
A Teva Pharmaceutical migraine-prevention drug has won FDA approval, the second therapy in this new drug class to receive the regulatory nod this year.
The Friday approval for the Teva (NYSE: TEVA) drug fremanezumab (Ajovy) came a little earlier... Read more »
Students and shoppers will soon be using technology developed by Aira, a San Diego startup that links vision-impaired people with “visual interpreters” via smartphone and smart glasses, to help them navigate their environments.
In recent weeks Aira announced that its accessibility... Read more »
Fidelity Investments is cooking up more blockchain and cryptocurrency-related products and services, with a goal of rolling some of them out in the next few months, CEO Abigail Johnson said Friday morning.
Johnson made the comments during an event held at... Read more »